Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine regimen for C-RINV in head and neck cancer
NCT05202275Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05202275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05202275.